	Novotech, an Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in skin research clinical trials.

	The Partnership formalizes a long-standing working relationship between the two.

	SRIS was established as a collaboration between Agency for Science, Technology and Research (A*STAR), National Healthcare Group (NHG) and Nanyang Technological University (NTU) to conduct high impact, inter-disciplinary skin research that would translate into improved health outcomes and quality of life.

	Novotech now has over 20 significant Partnerships with some of the leading medical institutions in the region. The Partnership Program is designed to bring access to investigators, KOLs, and up to 4 million patients for its international biotech clients.

	Novotech CEO Dr John Moller said the Partnership with SRIS will support the increasing demand from biotech clients for skin disorder studies in the Asia-Pacific region.

	For more information go to https://novotech-cro.com/